Bioorthogonal Palladium-Labile Prodrugs for Site-Specific Anticancer Therapy Asier Unciti-Broceta, University of Edinburgh, speaking at Discovery Chemistry Congress 2015.
Creating a Clinical Diagnostic Test from Discovery Through Launch with Mass Spectrometry Daniel Chelsky, Caprion Proteomics Inc, speaking at Diagnostics & Biomarkers 2015.
LC-High Resolution-MS in Clinical Labs: A Step Forward for TDM and Metabotyping Bertrand Rochat, Centre Hospitalier Universitaire Vaudois, speaking at Clinical Applications of Mass Spectrometry.
Capturing D Genome Variation for Wheat Improvement Eric Olson, Michigan State University, speaking at Advances in Plant Genomics 2014
Investigating the Kinetics of cAMP Accumulation in Human Primary Cells Using a Live-Cell cAMP Biosensor Elizabeth Rosethorne, Novartis, speaking at Advances in Biosensors and Biodetection.
Contributions of Mass Spectrometry in the Diagnosis and Management of Hypothalamic–pituitary–adrenal Axis Disorders Gregori Casals, Hospital Clínic Barcelona, speaking at Clinical Applications of Mass Spectrometry.
Biomarkers to Predict Aggressive Prostate Cancer Claire Morgan, Swansea University, speaking at Diagnostics & Biomarkers 2015.
Characterising Plant Genomes The Good The Bad and The Ugly Dave Edwards, University of Queensland, speaking at Advances in Plant Genomics 2014
Biomarkers from Discovery to Clinical Diagnostics Applications of Single-Molecule Array (Simoa) Technology Andreas Jeromin, Atlantic Biomarkers, speaking at Diagnostics & Biomarkers 2015.